![](https://investorshub.advfn.com/uicon/750370.png?cb=1607199114)
Wednesday, September 21, 2022 9:36:26 AM
The DSMB ruled in regards to $ADMP Tempol to treat COVID-19 just made a ruling at their meeting. They recommended that the study be halted early due to lack of efficacy. The club trying to develop an effective oral drug just got smaller.$RVVTF https://t.co/P9rHwxPw7B
— The Dales Report (@TheDalesReport) September 21, 2022
Ps. Bluehorse , I just read Dsa post as he say's : ) Adamis is done. We are the only ones left!
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM